Search research articles
Contact Us
Filters
Showing results (661-670 of 689) with videos related to
Page
of 69
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1990
IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells
R W Kozak, H Lorberboum-Galski, L Jones, et al.
AIDS Research and Human Retroviruses
|
June 1, 1990
Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions
E A Berger, V K Chaudhary, K A Clouse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1994
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies
L Camera, S Kinuya, K Garmestani, et al.
European Journal of Nuclear Medicine
|
July 1, 1994
Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)
L Camera, S Kinuya, K Garmestani, et al.
The Journal of Biological Chemistry
|
September 25, 1990
IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes
H Lorberboum-Galski, R J Garsia, M Gately, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts
C T Kuan, C J Reist, C F Foulon, et al.
The Journal of Urology
|
September 1, 1997
Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin
A Maini, G Hillman, G P Haas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 1998
Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies
H Kobayashi, C Wu, T M Yoo, et al.
Cancer Research
|
March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer
D J FitzGerald, M J Bjorn, R J Ferris, et al.
Cancer Research
|
November 15, 1995
Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts
C W Choi, L Lang, J T Lee, et al.
Page
of 69
Search research articles
Search
Showing results (661-670 of 689) with videos related to
Sort By:
Page
of 69
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1990
IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells
R W Kozak, H Lorberboum-Galski, L Jones, et al.
AIDS Research and Human Retroviruses
|
June 1, 1990
Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions
E A Berger, V K Chaudhary, K A Clouse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1994
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies
L Camera, S Kinuya, K Garmestani, et al.
European Journal of Nuclear Medicine
|
July 1, 1994
Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)
L Camera, S Kinuya, K Garmestani, et al.
The Journal of Biological Chemistry
|
September 25, 1990
IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes
H Lorberboum-Galski, R J Garsia, M Gately, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts
C T Kuan, C J Reist, C F Foulon, et al.
The Journal of Urology
|
September 1, 1997
Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin
A Maini, G Hillman, G P Haas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 1998
Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies
H Kobayashi, C Wu, T M Yoo, et al.
Cancer Research
|
March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer
D J FitzGerald, M J Bjorn, R J Ferris, et al.
Cancer Research
|
November 15, 1995
Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts
C W Choi, L Lang, J T Lee, et al.
Page
of 69